SAN DIEGO, May 20, 2019 /PRNewswire/ — Early research using blood-based methylated DNA markers, identified …
Read More »
BRUSSELS and ATLANTA, May 20, 2019 /PRNewswire/ — UCB announced today that the U.S. Food …
Read More »
CAMBRIDGE, England–(BUSINESS WIRE)–Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
SAN DIEGO, May 20, 2019 /PRNewswire/ — Early research using blood-based methylated DNA markers, identified …
Read More »
CAMBRIDGE, England–(BUSINESS WIRE)–Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease …
Read More »
BRUSSELS and ATLANTA, May 20, 2019 /PRNewswire/ — UCB announced today that the U.S. Food …
Read More »
NORTH CHICAGO, Ill., May 17, 2019 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical …
Read More »
LEXINGTON, Mass., May 17, 2019 /PRNewswire/ — Takeda Pharmaceuticals, U.S.A., Inc. (“Takeda”), announced today that …
Read More »
Hilden, Germany, Germantown, Maryland, and Plymouth Meeting, Pennsylvania, May 16, 2019 – QIAGEN N.V. (NYSE: QGEN; …
Read More »
The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, …
Read More »
NEW YORK, May 16, 2019 /PRNewswire/ –Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) …
Read More »
ALAMEDA, Calif. & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that it …
Read More »
BURLINGAME, Calif. & CALGARY, Alberta–(BUSINESS WIRE)–Parvus Therapeutics, a biopharmaceutical company focused on the development of …
Read More »
WHIPPANY, N.J., May 15, 2019 /PRNewswire/ — Bayer today announced findings from new analyses and …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in …
Read More »
BRENTWOOD, Tenn., May 15, 2019 /PRNewswire/ — Mayo Clinic and Premise Health, a direct health …
Read More »
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today positive top-line results from a Phase 3 …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
